Skip to main
  • Published

Go with the flow: Cystatin C use in solid organ transplant

Developed by AST's Transplant Pharmacy COP and American College of Clinical Pharmacy (ACCP), in partnership with AST's Liver and Intestinal, Kidney Pancreas, and Thoracic and Critical Care COPs.

View On-demand
Share

Objectives: 

  1. Identify the strengths and limitations of utilization of Cystatin C to assess renal function in solid organ transplant populations, including recipients and donors. 
  2. Review literature evaluating the relationship of use of cystatin C to clinical outcomes. 
  3. Review medication dosing principles with Cystatin C and apply cystatin C-based eGFR to clinical case(s) in transplant. 

Presenters: 

  • Vasanthi Balaraman, MD 
  • Sumeet Asrani, MD, MSc 
  • Erin Barreto, PharmD, MS 
  • Adley Lemke, PharmD 

Moderators: 

  • Jamie Schulte, PharmD 
  • Kelsea Zukauckas, PharmD 

This webinar is hosted by the AST Transplant Pharmacy Community of Practice (TxPharm COP) and the American College of Clinical Pharmacy (ACCP), with support from the Kidney Pancreas (KPCOP), Liver and Intestinal (LICOP) and Thoracic and Critical Care (TCC COP) Communities of Practice.

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

View Current Issue

Advertisements & Sponsors

This content was developed independently by AST and supported by a financial contribution from Sanofi